Figure 2
Figure 2. Potency of 14E11 and O1A6 varies depending on [TF]wall. Anticoagulated whole blood (CTI, 4 μg/mL) was treated with FXI antibody 14E11 or O1A6 (20 μg/mL) and was perfused over collagen/TF surfaces at 100 s−1 (constant Q). (A-C) Platelet deposition on collagen was unaffected by FXI antibodies despite the difference in [TF]wall. (D-E) O1A6 showed inhibitory effect on fibrin generation at low and medium [TF]wall. (D) 14E11 only reduced fibrin generation at low [TF]wall. (F) Neither of the antibodies caused reduction in fibrin at high [TF]wall. *P < .05; **P < .01.

Potency of 14E11 and O1A6 varies depending on [TF]wall. Anticoagulated whole blood (CTI, 4 μg/mL) was treated with FXI antibody 14E11 or O1A6 (20 μg/mL) and was perfused over collagen/TF surfaces at 100 s−1 (constant Q). (A-C) Platelet deposition on collagen was unaffected by FXI antibodies despite the difference in [TF]wall. (D-E) O1A6 showed inhibitory effect on fibrin generation at low and medium [TF]wall. (D) 14E11 only reduced fibrin generation at low [TF]wall. (F) Neither of the antibodies caused reduction in fibrin at high [TF]wall. *P < .05; **P < .01.

Close Modal

or Create an Account

Close Modal
Close Modal